Governance Documents

West's corporate governance leadership was recognized by Institutional Shareholders Services, which listed the Company in the Top Ten Corporate Governance Quotient Ranking in the Russell 3000 Index.

Eric M. Green
Eric M. Green has served as President and CEO of West Pharmaceutical Services, Inc. since April 2015 and as chair of the board since May 2022. As CEO, Eric leads over 10,000 team members dedicated to containing and delivering injectable therapies that improve patients’ lives.
Read More

Eric M. Green

President and Chief Executive Officer, Chair of Board

Shane Campbell
Shane Campbell joined West in May 2025 and serves as Senior Vice President and Chief Proprietary Segment Officer. Shane has extensive global-management experience across operations, engineering, commercial and strategy. He spent over 20 years at DuPont in roles of increasing responsibility focused
Read More

Shane Campbell

Senior Vice President, Chief Proprietary Segment Officer

Kathy dePadua
Kathy joined West in 2022 and serves as Senior Vice President, Chief Quality and Regulatory Officer. In her role, Kathy is responsible for overseeing the global Quality and Regulatory teams, supporting West’s priority of delivering high-quality products that meet the exact product specifications
Read More

Kathy dePadua

Senior Vice President, Chief Quality and Regulatory Officer

Annette F. Favorite
Annette F. Favorite serves as Senior Vice President and Chief Human Resources Officer for West Pharmaceutical Services, Inc. In her role, she leads West’s Human Resources and Global Communications functions and elevates team performance through innovative HR programs.
Read More

Annette F. Favorite

Senior Vice President, Chief Human Resources Officer

Norm Finch
Norman “Norm” D. Finch Jr. joined West as Senior Vice President, General Counsel and Corporate Secretary in December 2025. In his role, Norm is responsible for the global legal and compliance function company-wide, including litigation and intellectual property, serving as the primary legal advisor
Read More

Norm D. Finch

Senior Vice President, General Counsel and Secretary

Pat Makena
Pat serves as Senior Vice President and Chief Digital Officer (CDO) at West. In this role, he leads the company’s digital transformation journey, driving the development of digital capabilities, ensuring Digital & Transformation (D&T) initiatives are aligned with business strategic priorities, and
Read More

Pat Makena

Senior Vice President, Chief Digital Officer

Devesh Mathur
Dr. Devesh Mathur joined West as Senior Vice President and Chief Technology Officer in August 2025. In his role, Devesh is responsible for overseeing research initiatives alongside the West Applied Research and Advanced Engineering teams, with a focus on converting scientific and technical insights
Read More

Devesh Mathur

Sr. Vice President, Chief Technology Officer

Bob McMahon
Robert “Bob” McMahon joined West as Senior Vice President and Chief Financial Officer of West Pharmaceutical Services, Inc. in August of 2025. Bob had most recently served as Senior Vice President & Chief Financial Officer of Agilent Technologies Inc. since 2018.
Read More

Bob McMahon

Senior Vice President, Chief Financial Officer

Don O’Callaghan
Don O’Callaghan serves as President of Drug Delivery Devices. In this role, Don has global end-to-end responsibility for West’s proprietary drug device products, including strategic business development, product design and management, engineering, supply chain, and manufacturing operations.
Read More

Don O’Callaghan

President, Drug Delivery Devices

Andy Polywacz
Andy Polywacz serves as President of Integrated Systems. In this role, Andy has global responsibility for West’s Integrated System products, including strategic business development, product design and management, supply chain and operations. Prior to this role, Andy served as the Vice President of
Read More

Andy Polywacz

President, Integrated Systems

Rudy Poussot
Rudy Poussot joined West as Senior Vice President, Strategy and Corporate Development in November 2023. In his role, Rudy is responsible for overseeing the long-term strategic vision for West’s growth and capital deployment. Most recently, Rudy served as the Director of Health Strategy, Business
Read More

Rudy Poussot

Senior Vice President, Strategy and Corporate Development

Aileen Ruff-Patry
Aileen Ruff-Patry serves as President of Contract Manufacturing. In this role, Aileen has global end-to-end responsibility for West’s Contract Manufacturing Operating Unit, including sales and business development, strategic planning, marketing, engineering, supply chain, quality and manufacturing
Read More

Aileen Ruff-Patry

President, Contract Manufacturing

Deborah L.V. Keller
Ms. Keller serves as a Principal at Black Frame Advisors, LLC, and is the former CEO of Covance Drug Development—a business segment of Laboratory Corporation of America Holdings. Prior to serving as CEO, Ms. Keller spent more than 28 years at Covance in several leadership roles, including Corporate
read more

Deborah L.V. Keller

Principal, Black Frame Advisors, LLC and Former Chief Executive Officer, Covance Drug Development Director since 2017

Douglas A. Michels
Mr. Michels retired from OraSure Technologies, Inc. - a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions—in March 2018, after serving as President and CEO, as
read more

Douglas A. Michels

Retired President and Chief Executive Officer, OraSure Technologies, Inc. Director since 2011

Eric M. Green
Mr. Green has been our President and CEO since April 2015 and a member of our Board of Directors since May 2015. Mr. Green became the Chair of the Board in May of 2022. Mr. Green is responsible for leading West’s market led business strategy, focused on tailoring our approach to the specific needs
read more

Eric M. Green

Chair of the Board; West Pharmaceutical Services, Inc. Director since 2015 Chairman since 2022

Janet Haugen
Ms. Haugen is the former Chief Financial Officer of Unisys Corporation, a role she served in for more than 16 years. During her 20-year tenure at Unisys, Ms. Haugen oversaw the business transformation from a mainframe hardware, software and maintenance company to an IT services and software
read more

Janet B. Haugen

Retired Chief Financial Officer, Unisys Corporation Director since 2024

Mark A. Buthman
Mr. Buthman retired from Kimberly-Clark Corporation—a global producer of branded products for the consumer, professional and healthcare markets—in December 2015, where he was Executive Vice President and Chief Financial Officer from January 2003 to April 2015.
read more

Mark A. Buthman

Retired Executive Vice President and Chief Financial Officer, Kimberly-Clark Corporation Director since 2011

Molly E. Joseph
Ms. Joseph is the former Chief Executive Officer of UnitedHealthcare Global, a role she served in for more than a decade. During her 16-year tenure, she pioneered the establishment of UnitedHealth Group’s global health business into one of the largest health benefits and medical delivery businesses
read more

Molly E. Joseph

Managing Partner, Cypress Pass Ventures and Former Chief Executive Officer UnitedHealthcare Global Director since 2021

Myla P. Lai-Goldman, M.D.
Dr. Lai-Goldman is the Chair of GeneCentric Therapeutics, Inc.—a precision medicine company— where she previously served as CEO and President since June 2011. She is also managing partner of Personalized Science, LLC, a clinical diagnostic consulting company that she founded in 2008.
read more

Myla P. Lai-Goldman, M.D.

Chair and Former Chief Executive Officer and President, GeneCentric Therapeutics, inc. Director since 2014

Paolo Pucci
Mr. Pucci is the retired CEO and a former member of the Board of Directors of ArQule, Inc., a biopharmaceutical company engaged in the research and development of targeted therapeutics that was acquired by Merck & Co. in January 2020. Before joining ArQule in 2008, Mr.
read more

Paolo Pucci

Retired Chief Executive Officer, ArQule, Inc. Director since 2016

Robert F. Friel
Mr. Friel is the former Chair, President and CEO of PerkinElmer, Inc., and a former member of PerkinElmer’s board of directors. Mr. Friel retired as Chair and CEO of PerkinElmer, Inc., a global business dedicated to serving the diagnostics, life sciences, food and applied markets in December 2019.
read more

Robert F. Friel

Lead Independent Director, Retired Chair, President and Chief Executive Officer, PerkinElmer, Inc. (now Revvity, Inc.) Director since 2020

Stephen Lockhart, M.D., Ph.D.
Dr. Lockhart is the former Chief Medical Officer (CMO) of Sutter Health, a not-for-profit system of hospitals, physician or profit system of hospitals, physician organizations and research institutions in Northern California. Serving in this role for over seven years, he was responsible for
read more

Stephen H. Lockhart, M.D., Ph.D.

Retired Chief Medical Officer, Sutter Health Director since 2022

William F. Feehery, Ph.D.
Dr. Feehery served as CEO and a member of Certara’s board of directors from 2019 through December 2025. Certara is a public company that provides services and software that assist with the drug development lifecycle. Prior to his tenure at Certara, Dr.
read more

William F. Feehery, Ph.D.

Former Chief Executive Officer, Certara, Inc. Director since 2012

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.

Member Audit Committee Compensation Committee Nominating and Corporate Governance Committee
Mark A. Buthman
William F. Feehery, Ph.D.
Robert F. Friel
Janet B. Haugen
Molly E. Joseph
Deborah L.V. Keller
Myla P. Lai-Goldman, M.D.
Stephen H. Lockhart, M.D., Ph.D.
Douglas A. Michels
Paolo Pucci
= Chairperson = Member

Committee Details

The Board of Directors of West Pharmaceutical Services has adopted the following recent amendments to the Code of Business Conduct:

Date of Amendment: July 2022

Interested parties can communicate with the Chairman, Independent Directors or the non-management directors by sending a letter addressed as follows:

The Board of Directors
c/o Norm Finch
Senior Vice President, General Counsel and Corporate Secretary
530 Herman O. West Drive
Exton, PA 19341

Communications to a particular director should be addressed to that director at the same address.

The Senior Vice President, General Counsel and Corporate Secretary maintains a log of all communications received through this process. Communications to specific directors are forwarded to those directors. All other communications to us are transmitted directly to the Chairman, Independent Directors who decides whether these messages should be forwarded to a particular board committee or to management for further handling.